Triple Negative Breast Cancer (TNBC)

specific

Triple-negative breast cancer finding is a negative test result that occurs when the cells in the tumor of a breast cancer patient lack the receptors for both estrogen and progesterone and the human epidermal growth factor receptor 2.

62

Centers

60

Active Trials

$155M

Cancer Funding

Top Centers for Triple Negative Breast Cancer (TNBC)(62)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
80.4
2
High-Volume Research Center
74.8
3
High-Volume Research Center
74.1
4
NCI Comprehensive
High-Volume Research Center
73.8
5
NCI Comprehensive
High-Volume Research Center
72.1
6
NCI Comprehensive
High-Volume Research Center
71.3
768.6
8
NCI Comprehensive
Active Research Program
65.2
9
NCI Comprehensive
Active Research Program
64.8
10
NCI Comprehensive
Active Research Program
64.2
11
NCI Comprehensive
Active Research Program
64.1
12
NCI Comprehensive
Active Research Program
61.7
13
NCI Comprehensive
Active Research Program
60.3
14
NCI Comprehensive
Active Research Program
60.0
15
NCI Comprehensive
Active Research Program
59.2
16
NCI Comprehensive
Active Research Program
58.0
17
NCI Comprehensive
Active Research Program
55.5
18
NCI Comprehensive
Active Research Program
54.9
19
NCI Comprehensive
Active Research Program
54.1
2053.8
21
NCI Comprehensive
Active Research Program
53.5
22
NCI Comprehensive
Active Research Program
53.2
23
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
53.1
24
Active Research Program
53.1
25
NCI Comprehensive
Active Research Program
53.1
26
NCI Comprehensive
Active Research Program
52.9
27
NCI Comprehensive
Active Research Program
52.7
28
NCI Clinical
Active Research Program
52.4
29
NCI Clinical
Active Research Program
52.1
30
NCI Comprehensive
Active Research Program
51.5
31
NCI Comprehensive
Active Research Program
51.0
32
NCI Comprehensive
Active Research Program
50.7
33
NCI Comprehensive
Active Research Program
50.4
34
NCI Comprehensive
Active Research Program
49.8
35
NCI Basic_laboratory
Active Research Program
49.3
36
NCI Comprehensive
Active Research Program
48.7
37
NCI Comprehensive
Active Research Program
48.4
38
NCI Comprehensive
Active Research Program
45.9
39
Active Research Program
45.3
40
GW Cancer CenterWashington, DC
Active Research Program
44.8
41
NCI Comprehensive
Active Research Program
44.2
42
NCI Comprehensive
Active Research Program
43.6
43
NCI Comprehensive
Active Research Program
43.6
44
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
43.6
45
Active Research Program
43.6
46
Active Research Program
43.6
47
Active Research Program
43.6
48
Active Research Program
43.6
49
Active Research Program
43.6
50
NCI Comprehensive
Active Research Program
43.1
51
NCI Comprehensive
Active Research Program
41.9
52
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
39.7
53
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
39.1
54
NCI Comprehensive
Active Research Program
38.5
55
NCI Basic_laboratory
Active Research Program
37.4
56
NCI Comprehensive
Active Research Program
36.9
57
NCI Comprehensive
Contributing Research Center
34.0
58
Contributing Research Center
33.5
59
NCI Comprehensive
Contributing Research Center
32.3
60
NCI Comprehensive
25.8
61
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
25.8
6225.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →